Ballicules.com

Valbenazine

INGREZZA

What it isReversible VMAT2 inhibitor that reduces presynaptic dopamine packaging; tardive dyskinesia.

Why this oneIt usually needs less titration than deutetrabenazine and lets the causative antipsychotic continue.

What limits itSomnolence and QT prolongation; CYP2D6 or CYP3A4 inhibition raises exposure.

FDA-approved for

FDA label

BOXED WARNING Increases risk of depression and suicidal ideation/behavior in patients with Huntington's disease.
FDA dosingPopulationStartTargetMax
Tardive dyskinesiaAdults40 mg QD80 mg QD (after 1 wk); 40–60 mg QD per response80 mg QD
Chorea associated with Huntington's diseaseAdults40 mg QD80 mg QD (↑20 mg q2wk); 40–60 mg QD per response80 mg QD

Titration Tardive dyskinesia: increase after 1 week. Huntington's chorea: increase in 20 mg increments every 2 weeks.

Renal Undefined

Hepatic Moderate or severe hepatic impairment: 40 mg QD.

Instructions

Cautions

Adverse reactions

Pregnancy Insufficient human data; animal data show increased stillbirths/pup mortality — may cause fetal harm.

Lactation Do not breastfeed during treatment and for 5 days after the final dose.

NO BOXED WARNINGS

Principal riskSomnolence and QT prolongation

Cost, est. cash$3,000–$10,000/month

Generic entry2038 (settlement)

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryNot assigned — PLLR-era drug

Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Mechanism of action: Valbenazine ballicule

Valbenazine ballicule: receptor binding, kinetics and half-life diagram

Open Valbenazine in the interactive console ↗

Memory aids: mascots and interaction avatars

Valbenazine INGREZZA mascot mnemonic cartoon
“Valved bin In grease”
QT prolongation
Valbenazine CYP2D6 substrate avatar
CYP2D6 substrate
Valbenazine CYP3A4 substrate avatar
CYP3A4 substrate

Open Valbenazine in the interactive console ↗